Early proximal lung cancer diagnosis and treatment

European Respiratory Journal

Volumn 33, Issue 3, 2009, Pages 656-665

  McWilliams, A ^a,d   Lam, B ^b   Sutedja, T ^c  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; BRONCHOSCOPY; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; LUNG SURGERY; MINIMALLY INVASIVE PROCEDURE; NON INVASIVE PROCEDURE; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; SPUTUM CYTODIAGNOSIS; TREATMENT OUTCOME;

BRONCHOSCOPY; CLINICAL TRIALS AS TOPIC; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MEDICAL ONCOLOGY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RISK; SMALL CELL LUNG CARCINOMA; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 61649117003     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00124608     Document Type: Article

References (114)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics 2006. CA Cancer J Clin 2006; 56: 106-130.
2. Woodward RM, Martin ML, Cronin KA, Cutler DM. The value of medical interventions for lung cancer in the elderly. Results from SEER-CMHSF. Cancer 2007; 110: 2511-2518.
3. Janssen-Heijnen ML, Coeburgh JW. Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe. Lung Cancer 2001; 31: 123-137.
4. Sato M, Saito Y, Endo C, et al. The natural history of radiographically occult bronchogenic squamous cell carcinoma: a retrospective study of overdiagnosis bias. Chest 2004; 126: 108-113.
5. Breuer RH, Pasic A, Smit EF, et al. The natural course of preneoplastic lesions in bronchial epithelium. Clin Cancer Res 2005; 11: 537-543.
6. Cortese D, Pairolero P, Bergstralh E, et al. Roentgenographically occult lung cancer. A ten-year experience. J Thorac Cardiovasc Surg 1983; 86: 373-380.
7. Fujimura S, Sagawa M, Saito Y, et al. A therapeutic approach to roentgenographically occult squamous cell carcinoma of the lung. Cancer 2000; 89: Suppl. 11, 2445-2448.
8. Nakamura H, Kawasaki N, Hagiwara M, et al. Early hilar lung cancer - risk for multiple lung cancers and clinical outcome. Lung Cancer 2001; 33: 51-57.
9. Kennedy TC, McWilliams A, Edell E, et al. American College of Chest Physicians. Bronchial intraepithelial neoplasia/early central airways lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132: Suppl. 3, 221S-233S.
10. Woolner L, Fontana R, Cortese D, et al. Roentgenographically occult lung cancer; pathologic findings and frequency of multicentricity during a 10-year period. Mayo Clin Proc 1984; 59: 453-466.
11. Vonk-Noordegraaf A, Postmus P, Sutedja T. Bronchoscopic treatment of patients with intraluminal microinvasive radiographically occult lung cancer not eligible for surgical resection: a follow-up study. Lung Cancer 2003; 39: 49-53.
12. Lam S, MacAulay C, Hung J, LeRiche J, Profio A, Palcic B. Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. J Thorac Cardiovasc Surg 1993; 105: 1035-1040.
13. Pierard P, Vermylen P, Bosschaerts T, et al. Synchronous roentgenographically occult lung carcinoma in patients with resectable primary lung cancer. Chest 2000; 117: 779-785.
14. Pierard P, Faber J, Hutsebaut J, et al. Synchronous lesions detected by autofluorescence bronchoscopy in patients with high-grade preinvasive lesions and occult invasive squamous cell carcinoma of the proximal airways. Lung Cancer 2004; 46: 341-347.
15. van Rens M, Schramel F, Elbers J, Lammers J. The clinical value of lung imaging fluorescence endoscopy for detecting synchronous lung cancer. Lung Cancer 2001; 32: 13-18.
16. Venmans B, van Boxem T, Smit E, Postmus P, Sutedja T. Outcome of bronchial carcinoma in situ. Chest 2000; 117: 1572-1576.
17. Deygas N, Froudarakis M, Ozenne G, Vergnon JM. Cryotherapy in early superficial bronchogenic carcinoma. Chest 2001; 120: 26-31.
18. Bota S, Auliac J, Paris C, et al. Follow-up of bronchial precancerous lesions and carcinoma in situ using fluorescence endoscopy. Am J Respir Crit Care Med 2001; 164: 1688-1693.
19. Moro-Sibilot D, Fievet F, Jeanmart M, et al. Clinical prognostic indicators of high-grade pre-invasive bronchial lesions. Eur Respir J 2004; 24: 24-29.
20. George P, Banerjee A, Read C, et al. Surveillance for the detection of early lung cancer in patients with bronchial dysplasia. Thorax 2007; 62: 43-50.
21. Terzi A, Pelosi G, Falezza G, Lonardoni A, Pasini F, Calabró F. Early hilar lung cancer - clinical aspects and long term survival. Identification of a subgroup of stage IA patients with more favorable prognosis. Lung Cancer 2000; 27: 119-124.
22. Bolliger CT, Sutedja TG, Strausz J, Freitag L. Therapeutic bronchoscopy with immediate effect: laser, electrocautery, argon plasma coagulation and stents. Eur Respir J 2006; 27: 1258-1271.
23. Motherby H, Nicklaus S, Berg A, et al. Semiautomated monolayer preparation of bronchial secretions using AutoCyte PREP. Acta Cytol 1999; 43: 47-57.
24. Agusti C, Xaubet A, Monton C, et al. Induced sputum in the diagnosis of peripheral lung cancer not visible endoscopically. Respir Med 2001; 95: 822-828.
25. Choi YD, Han CW, Kim JH, et al. Effectiveness of sputum cytology using ThinPrep method for evaluation of lung cancer. Diagn Cytopathol 2008; 36: 167-171.
26. Holiday DB, McLarty JW, Farley ML, et al. Sputum cytology within and across laboratories. A reliability study. Acta Cytol 1995; 39: 195-206.
27. Byers T, Wolf HJ, Franklin WA, et al. Sputum cytologic atypia predicts incident lung cancer: defining latency and histologic specificity. Cancer Epidemiol Biomarkers Prev 2008; 17: 158-162.
28. van Oppen Toth, Meisels A, St-Pierre S. Malignancy associated changes in sputum: a correlated study of 315 patients. Acta Cytol 1975; 19: 573-576.
29. MacAulay C, Lam S, Payne P, LeRiche J, Palcic B. Malignancy associated changes in bronchial epithelial cells in biopsies. Anal Quant Cytol Histol 1995; 17: 55-61.
30. Ikeda N, MacAulay C, Lam S, et al. Malignancy associated changes in bronchial epithelial cells and clinical application as a biomarker. Lung Cancer 1998; 19: 161-166.
31. Palcic B, Garner DM, Beveridge J, et al. Increase of sensitivity of sputum cytology using high-resolution image cytometry: field study results. Cytometry 2002; 50: 168-176.
32. Xing S, Khanavkar B, Nakhosteen JA, et al. Predictive value of image cytometry for diagnosis of lung cancer in heavy smokers. Eur Respir J 2005; 25: 956-963.
33. Kemp RA, Reinders DM, Turic B. Detection of lung cancer by automated sputum cytometry. J Thorac Oncol 2007; 2: 993-1000.
34. Marek W, Richartz G, Philippou S, Marek L, Kotschy-Lang N. Sputum screening for lung cancer in radon exposed uranium miners: a comparison of semi-automated sputum cytometry and conventional cytology. J Physiol Pharmacol 2007; 58: Suppl. 5, 349-361.
35. Chhajed PN, Shibuya K, Hoshino H, et al. A comparison of video and autofluorescence bronchoscopy in patients at high risk of lung cancer. Eur Respir J 2005; 25: 951-955.
36. Shibuya K, Hoshino H, Chiyo M, et al. Subepithelial vascular patterns in bronchial dysplasias using a high magnification bronchovideoscope. Thorax 2002; 57: 902-907.
37. Wagnieres G, McWilliams A, Lam S. Lung cancer imaging with fluorescence endoscopy. In: Mycek M, Pogue B, eds. Handbook of Biomedical Fluorescence. New York, Marcel Dekker, 2003; pp. 361-396.
38. Lam S, Kennedy T, Unger M, et al. Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy. Chest 1998; 113: 696-702.
39. Ernst A, Simoff MJ, Mathur PN, Yung RC, Beamis Jr JF. D-light autofluorescence in the detection of premalignant airway changes: a multicenter trial. J Bronchol 2005; 12: 133-138.
40. Edell E, Lam S, Pass H, et al. Detection and localization of intraepithelial neoplasia and invasive carcinoma using fluorescence-reflectance bronchoscopy: an international, multicenter clinical trial. J Thorac Oncol 2009; 4: 49-54.
41. Hirsch FR, Prindiville SA, Miller YE, et al. Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study. J Natl Cancer Inst 2001; 93: 1385-1391.
42. Häussinger K, Becker H, Stanzel F, et al. Autofluorescence bronchoscopy with white light bronchoscopy compared with white light bronchoscopy alone for the detection of precancerous lesions: a European randomized controlled multicentre trial. Thorax 2005; 60: 496-503.
43. Hung J, Lam S, leRiche J, Palcic B. Autofluorescence of normal and malignant bronchial tissue. Laser Surg Med 1991; 11: 99-105.
44. Qu J, MacAulay C, Lam S, Palcic B. Laser-induced fluorescence spectroscopy at endoscopy: tissue optics, monte carlo modeling, and in vivo measurements. Opt Eng 1995; 34: 3334-3343.
45. Qu J, MacAulay C, Lam S, Palcic B. Optical properties of normal and carcinoma bronchial tissue. Appl Optics 1994; 33: 7397-7405.
46. Lam S, MacAulay C, Leriche J, Ikeda N, Palcic B. Early localization of bronchogenic carcinoma. Diagn Ther Endosc 1994; 1: 75-78.
47. Lam S, MacAulay C, Leriche J, Palcic B. Detection and localization of early lung cancer by fluorescence bronchoscopy. Cancer 2000; 89: Suppl. 11, 2468-2473.
48. Venmans BJW, van Boxem AJM, Smit EF, et al. Early detection of preinvasive lesions in high-risk patients. A comparison of conventional flexible and fluorescence bronchoscopy. J Bronchology 1998; 5: 280-283.
49. Vermylen P, Pierard P, Roufosse C, et al. Detection of bronchial preneoplastic lesions and early lung cancer with fluorescence bronchoscopy: a study about its ambulatory feasibility under local anesthesis. Lung Cancer 1999; 25: 161-168.
50. Horvath T, Horvathova M, Salajka F, et al. Detection of bronchial neoplasia in uranium miners by autofluorescence bronchoscopy. Diagn Ther Endosc 1999; 5: 91-98.
51. Kusunoki Y, Imamura F, Uda H, Mano M, Horai T. Early detection of lung cancer with laser-induced fluorescence endoscopy and spectrofluorometry. Chest 2000; 118: 1776-1782.
52. Shibuya K, Fujisawa T, Hoshino H, et al. Fluorescence bronchoscopy in the detection of preinvasive bronchial lesions in patients with sputum cytology suspicious or positive for malignancy. Lung Cancer 2001; 32: 19-25.
53. Sato M, Sakurada A, Sagawa M, et al. Diagnostic results before and after introduction of autofluorescence bronchoscopy in patients suspected of having lung cancer detected by sputum cytology in lung cancer mass screening. Lung Cancer 2001; 32: 247-253.
54. Goujon D, Zellweger M, Radu A, et al. In vivo autofluorescence imaging of early cancers in the human tracheobronchial tree with a spectrally optimized system. Biomed Opt Journal 2003; 8: 17-25.
55. Fielding D. Practical issues in autofluorescence bronchoscopy with Storz D Light bronchoscope. Photodiagn Photodynam Ther 2004; 1: 247-251.
56. Kennedy TC, Franklin WA, Prindiville SA, et al. High prevalence of occult endobronchial malignancy in high risk patients with moderate sputum atypia. Lung Cancer 2005; 49: 187-191.
57. Sutedja TG, Codrington H, Risse EK, et al. Autofluorescence bronchoscopy improves staging of radiographically occult lung cancer and has an impact on therapeutic strategy. Chest 2001; 120: 1327-1332.
58. Ikeda N, Hiyoshi T, Kakihana M, et al. Histopathological evaluation of fluorescence bronchoscopy using resected lungs in cases of lung cancer. Lung Cancer 2003; 41: 303-309.
59. Ikeda N, Honda H, Hayashi A, et al. Early detection of bronchial lesions using newly developed videoendoscopy-based autofluorescence bronchoscopy. Lung Cancer 2006; 52: 21-27.
60. Chiyo M, Shibuya K, Hoshino H, et al. Effective detection of bronchial preinvasive lesions by a new autofluorescence imaging bronchovideoscope system. Lung Cancer 2005; 48: 307-313.
61. Helfritzsch H, Junker K, Bartel M, Scheele J. Differentiation of positive autofluorescence bronchoscopy findings by comparative genomic hybridization. Oncol Rep 2002; 9: 697-701.
62. Pasic A, Vonk-Noordegraaf A, Risse EK, Postmus PE, Sutedja TG. Multiple suspicious lesions detected by autofluorescence bronchoscopy predictmalignant development in the bronchial mucosa in high risk patients. Lung Cancer 2003; 41: 295-301.
63. Lee P, McWilliams A, Lam S, Sutedja T. Quantitative image analysis for intra-epithelial neoplasia. J Thorac Oncol 2007; 2: Suppl. 4, S812.
64. Huang D, Swanson EA, Lin CP, Schuman JS, et al. Optical coherence tomography. Science 1991; 254: 1178-1181.
65. Fujimoto JG, Brezinski ME, Tearney GJ, et al. Biomedical imaging and optical biopsy using optical coherence tomography. Nat Med 1995; 1: 970-972.
66. Tearney GJ, Brezinski ME, Bouma BE, et al. In vivo endoscopic optical biopsy with optical coherence tomography. Science 1997; 276: 2037-2039.
67. Tsuboi M, Hayashi A, Ikeda N, et al. Optical coherence tomography in the diagnosis of bronchial lesions. Lung Cancer 2005; 49: 387-394.
68. Whiteman SC, Yang Y, van Pittius DG, Stephens M, Parmer J, Spiteri MA. Optical coherence tomography: real-time imaging of bronchial airways microstructure and detection of inflammatory/neoplastic morphological changes. Clin Cancer Res 2006; 12: 813-818.
69. Lam S, Standish B, Baldwin C, et al. In-vivo optical coherence tomography imaging of pre-invasive bronchial lesions. Clin Cancer Res 2008; 14: 2006-2011.
70. Yang VX, Vitkin IA. Principles of Doppler optical coherence tomography. In: Regar E, van Leeuwen T, Serruys P. Handbook of Optical Coherence Tomography in Cardiology. Oxford, Taylor and Francis Medical, 2006; pp. 305-318.
71. Li H, Standish BA, Mariampillai A, et al. Feasibility of interstitial Doppler optical coherence tomography for in vivo detection of microvascular changes during photodynamic therapy. Lasers Surg Med 2006; 38: 754-761.
72. Shibuya K, Hoshino H, Chiyo M, et al. High magnification bronchovideoscopy combined with narrow band imaging could detect capillary loos of angiogenic squamous dysplasia in heavy smokers at high risk for lung cancer. Thorax 2003; 58: 989-995.
73. Keith R, Miller Y, Gemmill R, et al. Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer. Clinic Cancer Res 2000; 6: 1616-1625.
74. Vincent B, Fraig M, Silvestri G. A pilot study of narrow-band imaging compared to white light bronchoscopy for evaluaton of normal airways and premalignant and malignant airways disease. Chest 2007; 131: 1794-1799.
75. Moro-Sibilot D, Jeanmart M, Lantuejoul S, et al. Cigarette smoking, preinvasive bronchial lesions, and autofluorescence bronchoscopy. Chest 2002; 122: 1902-1908.
76. Jonsson S, Varella-Garcia M, Miller YE, et al. Chromosomal aneusomy in bronchial high-grade lesions is associated with invasive lung cancer. Am J Respir Crit Care Med 2008; 177: 342-347.
77. Jeanmart M, Lantuejoul S, Fievet F, et al. Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer. Clin Cancer Res 2003; 9: 2195-2203.
78. Breuer R, Snijders P, Sutedja T, et al. Suprabasal p53 immunostaining in premalignant endobronchial lesions in combination with histology is associated with bronchial cancer. Lung Cancer 2003; 40: 165-172.
79. Miyazu Y, Miyazawa T, Hiyama K, et al. Telomerase expression in noncancerous bronchial epithelia is a possible marker of early development of lung cancer. Cancer Res 2005; 65: 9623-9627.
80. Hoshino H, Shibuya K, Chiyo M, et al. Biological features of bronchial squamous dysplasia followed up by autofluorescence bronchoscopy. Lung Cancer 2004; 46: 187-196.
81. Thiberville L, Moreno-Swirc S, Vercauteren T, Peltier E, Cavé C, Bourg Heckly G. In vivo imaging of the bronchial wall microstructure using fibered confocal fluorescence microscopy. Am J Respir Crit Care Med 2007; 175: 22-31.
82. Huang Z, McWilliams A, Lui H, McLean DI, Lam S, Zeng H. Near-infrared Raman spectroscopy for optical diagnosis of lung cancer. Int J Cancer 2003; 107: 1047-1052.
83. Seibel EJ, Smithwick QY. Unique features of optical scanning, single fiber endoscopy. Lasers Surg Med 2002; 30: 177-183.
84. Anantham D, Feller-Kopman D, Shanmugham LN, et al. Electromagnetic navigation bronchoscopy-guided fiducial placement for robotic stereotactic radiosurgery of lung tumors: a feasibility study. Chest 2007; 132: 930-935.
85. Konaka C, Hirano T, Kato H, et al. Comparison of endoscopic features of early-stage squamous cell lung cancer and histological findings. Br J Cancer 1999; 80: 1435-1439.
86. Furukawa K, Kato H, Konaka C, Okunaka T, Usuda J, Ebihara Y. Locally recurrent central-type early stage lung cancer <1.0 cm in diameter after complete remission by photodynamic therapy. Chest 2005; 128: 3269-3275.
87. Kurimoto N, Murayama M, Yoshioka S, Nishisaka T, Inai K, Dohi K. Assessment of usefulness of endobronchial ultrasonography in determination of depth of tracheobronchial tumor invasion. Chest 1999; 115: 1500-1506.
88. Miyazu Y, Miyazawa T, Kurimoto N, Iwamoto Y, Kanoh K, Kohno N. Endobronchial ultrasonography in the assessment of centrally located early-stage lung cancer before photodynamic therapy. Am J Respir Crit Care Med 2002; 165: 832-837.
89. Takahashi H, Sagawa M, Sato M, et al. A prospective evaluation of transbronchial ultrasonography for assessment of depth of invasion in early bronchogenic squamous cell carcinoma. Lung Cancer 2003; 42: 42-49.
90. Herth F, Becker H, LoCicero J, Ernst A. Endobronchial ultrasound improves classification of suspicious lesions detected by autofluorescence bronchoscopy. J Bronchol 2003; 10: 249-252.
91. Pasic A, Brokx HA, Comans EF, et al. Detection and staging of preinvasive lesions and occult lung cancer in the central airways with 18F-fluorodeoxyglucose positron emission tomography: a pilot study. Clin Cancer Res 2005; 11: 6186-6189.
92. Gould M, Kuschner W, Rydzak C, et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med 2003; 139: 879-992.
93. Toloza E, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003; 123: Suppl. 1, 137S-146S.
94. Yasufuku K, Nakajima T, Motoori K, et al. Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer. Chest 2006; 130: 710-718.
95. van Boxem A, Westerga J, Venmans B, Postmus P, Sutedja G. Photodynamic therapy, Nd-YAG laser and electrocautery for treating early-stage intraluminal cancer: which to choose? Lung Cancer 2001; 31: 31-36.
96. Furuse K, Fukuoka M, Kato H, et al. A prospective phase-II study on photodynamic therapy for centrally located early-stage lung cancer. J Clin Oncol 1993; 11: 1852-1857.
97. Pasic A, Brokx HA, Vonk Noordegraaf A, Paul RM, Postmus PE, Sutedja TG. Cost-effectiveness of early intervention: comparison between intraluminal bronchoscopic treatment and surgical resection for T1N0 lung cancer patients. Respiration 2004; 71: 391-396.
98. Bolliger CT, Mathur PN, Beamis JF, et al. ERS/ATS statement on interventional pulmonology. European Respiratory Society/American Thoracic Society. Eur Respir J 2002; 19: 356-373.
99. Hayata Y, Kato H, Konaka C, Ono J, Takizawa N. Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. Chest 1982; 81: 269-277.
100. Kato H. Photodynamic therapy for lung cancer - a review of 19 years' experience. J Photochem Photobiol B 1998; 42: 96-99.
101. Kato H, Harada M, Usuda J, Tsuchida T, Okunaka T. Photodynamic therapy (PDT) of lung cancer: experience of the Tokyo Medical University. Photodiagn Photodynam Ther B 2004; 1: 49-55.
102. Usuda J, Kato H, Okunaka T, et al. Photodynamic therapy using Laserphyrin for centrally located early stage lung cancer. J Clin Oncol 2006; 24: Suppl. 18S, 7229.
103. Sutedja T, Lam S, LeRiche J, Postmus P. Response and pattern of failure after photodynamic therapy for intraluminal stage 1 lung cancer. J Bronchol 1994; 1: 295-298.
104. Cortese D, Edell E, Kinsey J. Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin Proc 1997; 72: 595-602.
105. Kato H, Furukawa K, Sato M, et al. Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung. Lung Cancer 2003; 42: 103-111.
106. Usuda J, Tsutsui H, Honda H, et al. Photodynamic therapy for lung cancers based on novel photodynamic diagnosis using talaporfin sodium (NPe6) and autofluorescence bronchoscopy. Lung Cancer 2007; 58: 317-323.
107. Deygas N, Froudarakis M, Ozenne G, Vergnon JM. Cryotherapy in early superficial bronchogenic carcinoma. Chest 2001; 120: 26-31.
108. Van Boxem T, Venmans B, Schramel F, et al. Radiographically occult lung cancer treated with fiberoptic bronchoscopic electrocautery: a pilot study of a simple and inexpensive technique. Eur Respir J 1998; 11: 169-172.
109. Vonk Noordegraaf A, Postmus PE, Sutedja TG. Bronchoscopic treatment of patients with intraluminal microinvasive radiographically occult lung cancer not eligible for surgical resection: a follow-up study. Lung Cancer 2003; 39: 49-53.
110. Pérol M, Caliandro R, Pommier P, et al. Curative irradiation of limited endobronchial carcinomas with high dose brachytherapy: results of a pilot study. Chest 1997; 111: 1417-1423.
111. Marsiglia H, Baldeyrou P, Lartigau E, et al. High-doserate brachytherapy as sole modality for early-stage endobronchial carcinoma. Int J Radiation Oncol Biol Phys 2000; 47: 665-672.
112. Cavaliere S, Foccoli P, Toninelli C. Curative bronchoscopic laser therapy for surgically resectable tracheobronchial tumors. J Bronchol 2002; 9: 90-95.
113. Sutedja G, van Boxem AJ, Postmus PE. The curative potential of intraluminal bronchoscopic treatment for early-stage non-small-cell lung cancer. Clin Lung Cancer 2001; 2: 264-270.
114. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006; 24: 4833-4839.